Prescient Healthcare Group Acquires Dolon

April 1, 2026

Prescient Healthcare Group has acquired Dolon, a London-based consultancy specializing in strategic pricing and market access for biopharma. The deal is intended to expand Prescient’s value, pricing, and access capabilities across the drug lifecycle, supported by Prescient’s investor Bridgepoint.

Buyers
Prescient Healthcare Group, Bridgepoint (supporting investor)
Targets
Dolon
Location
United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.